TP53 and serous adenocarcinoma: However, although various histological subtypes may not equally share TGF-β/Smad/UCHL5 axis function with those carrying TP53 mutation, we consider that the concept may be applicable to the possibility of a critical role of UCHL5 at least in TP53-mutant serous carcinoma.